Shiu SW - Search Results

1

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.

Tam HL, Shiu SW, Wong Y, Chow WS, Betteridge DJ, Tan KC. Tam HL, et al. Among authors: shiu sw. Atherosclerosis. 2010 Mar;209(1):173-7. doi: 10.1016/j.atherosclerosis.2009.08.031. Epub 2009 Aug 21. Atherosclerosis. 2010. PMID: 19733353

2

Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y. Tan KC, et al. Among authors: shiu sw. Eur J Clin Invest. 2003 Apr;33(4):301-6. doi: 10.1046/j.1365-2362.2003.01132.x. Eur J Clin Invest. 2003. PMID: 12662160

3

Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Tam S. Tan KC, et al. Among authors: shiu sw. Atherosclerosis. 2005 Feb;178(2):365-70. doi: 10.1016/j.atherosclerosis.2004.09.005. Atherosclerosis. 2005. PMID: 15754464

4

Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Wong WK, Tam S. Tan KC, et al. Among authors: shiu sw. Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):307-12. doi: 10.1002/dmrr.616. Diabetes Metab Res Rev. 2006. PMID: 16389649

5

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Tan KC, et al. Among authors: shiu sw. Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649

6

Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.

Zhou H, Tan KC, Shiu SW, Wong Y. Zhou H, et al. Among authors: shiu sw. Nephrol Dial Transplant. 2008 Mar;23(3):927-33. doi: 10.1093/ndt/gfm631. Epub 2007 Dec 8. Nephrol Dial Transplant. 2008. PMID: 18065800

7

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus.

Tan KC, Shiu SW, Wong Y, Leng L, Bucala R. Tan KC, et al. Among authors: shiu sw. J Lipid Res. 2008 Jul;49(7):1438-44. doi: 10.1194/jlr.M700551-JLR200. Epub 2008 Apr 12. J Lipid Res. 2008. PMID: 18408244 Free article.

8

Type 2 diabetes mellitus and endothelial lipase.

Shiu SW, Tan KC, Huang Y, Wong Y. Shiu SW, et al. Atherosclerosis. 2008 Jun;198(2):441-7. doi: 10.1016/j.atherosclerosis.2008.03.012. Epub 2008 Mar 22. Atherosclerosis. 2008. PMID: 18433755 Clinical Trial.

9

Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus.

Zhou H, Tan KC, Shiu SW, Wong Y. Zhou H, et al. Among authors: shiu sw. Metabolism. 2008 Aug;57(8):1135-40. doi: 10.1016/j.metabol.2008.03.020. Metabolism. 2008. PMID: 18640393

10

Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus.

Shiu SW, Tan KC, Wong Y, Leng L, Bucala R. Shiu SW, et al. Atherosclerosis. 2009 Apr;203(2):522-7. doi: 10.1016/j.atherosclerosis.2008.07.012. Epub 2008 Jul 23. Atherosclerosis. 2009. PMID: 18755461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters